You just read:

MabVax Therapeutics' Antibody Discovery Platform and HuMab-5B1 Cancer Therapeutic Featured in Presentation at America's Antibody Congress

News provided by

MabVax Therapeutics Holdings, Inc.

19 May, 2016, 08:00 ET